Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Group IIA secretory phospholipase A2 (sPLA2-IIA) is an enzyme that catalyzes the hydrolysis of the sn-2 ester bond in glycerophospholipids, releasing free fatty acids and lysophospholipids. It plays a role in inflammatory responses and antimicrobial activity. Elevated levels are observed in various inflammatory diseases, making it a potential biomarker. sPLA2-IIA also induces production of VEGF-A and VEGF-C, implicating it in angiogenesis.
Hydrolyzes sn-2 ester bond in glycerophospholipids, releasing free fatty acids and lysophospholipids. Catalysis involves His48/Asp99/calcium complex.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Group IIA Secretory Phospholipase A2 (sPLA2-IIA).